SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-024603
Filing Date
2021-05-06
Accepted
2021-05-06 10:03:10
Documents
88
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 ATNX - 10-Q - 20210331 atnx-10q_20210331.htm   iXBRL 10-Q 2798903
2 EX-10.2 atnx-ex102_182.htm EX-10.2 216512
3 EX-31.1 atnx-ex311_7.htm EX-31.1 16786
4 EX-31.2 atnx-ex312_9.htm EX-31.2 16437
5 EX-32.1 atnx-ex321_8.htm EX-32.1 11286
  Complete submission text file 0001564590-21-024603.txt   12564914

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA atnx-20210331.xsd EX-101.SCH 78074
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atnx-20210331_cal.xml EX-101.CAL 65934
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atnx-20210331_def.xml EX-101.DEF 262529
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE atnx-20210331_lab.xml EX-101.LAB 579817
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atnx-20210331_pre.xml EX-101.PRE 462142
11 EXTRACTED XBRL INSTANCE DOCUMENT atnx-10q_20210331_htm.xml XML 2923975
Mailing Address 1001 MAIN STREET SUITE 600 BUFFALO NY 14203
Business Address 1001 MAIN STREET SUITE 600 BUFFALO NY 14203 716-898-8625
Athenex, Inc. (Filer) CIK: 0001300699 (see all company filings)

IRS No.: 431985966 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38112 | Film No.: 21896232
SIC: 2834 Pharmaceutical Preparations